Weber, C. & Noels, H. Atherosclerosis: current pathogenesis and therapeutic options. Nat. Med. 17, 1410–1422 (2011).
Hansson, G. K. & Libby, P. The immune response in atherosclerosis: a double-edged sword. Nat. Rev. Immunol. 6, 508–519 (2006).
Laurat, E. et al. In vivo downregulation of T helper cell 1 immune responses reduces atherogenesis in apolipoprotein E-knockout mice. Circulation 104, 197 (2001).
Danzaki, K. et al. Interleukin-17A deficiency accelerates unstable atherosclerotic plaque formation in apolipoprotein E-deficient mice. Arterioscler. Thromb. Vasc. Biol. 32, 273 (2012).
Goodson, N., Marks, J., Lunt, M. & Symmons, D. Cardiovascular admissions and mortality in an inception cohort of patients with rheumatoid arthritis with onset in the 1980s and 1990s. Ann. Rheum. Dis. 64, 1595–1601 (2005).
Kimball, A. B. et al. Cardiovascular disease and risk factors among psoriasis patients in two US healthcare databases, 2001–2002. Dermatology 217, 27–37 (2008).
Roman, M. J. et al. Prevalence and correlates of accelerated atherosclerosis in systemic lupus erythematosus. N. Engl. J. Med. 349, 2399–2406 (2003).
Yu, H.-H. et al. Statin reduces mortality and morbidity in systemic lupus erythematosus patients with hyperlipidemia: a nationwide population-based cohort study. Atherosclerosis 243, 11–18 (2015).
Ghazizadeh, R., Tosa, M. & Ghazizadeh, M. Clinical improvement in psoriasis with treatment of associated hyperlipidemia. Am. J. Med. Sci. 341, 394–398 (2011).
Cai, Y., Fleming, C. & Yan, J. New insights of T cells in the pathogenesis of psoriasis. Cell. Mol. Immunol. 9, 302–309 (2012).
Ryu, H. & Chung, Y. Regulation of IL-17 in atherosclerosis and related autoimmunity. Cytokine 74, 219–227 (2015).
Choi, J.-Y. et al. Circulating follicular helper–like T cells in systemic lupus erythematosus: association with disease activity. Arthritis Rheumatol. 67, 988–999 (2015).
McGeachy, M. J., Singh, D., Henkel, M. & Moreland, L. Th17/TfH cells in rheumatoid arthritis: correlations with disease activity and therapy response. J. Immunol. 196, 51.23 (2016).
Lim, H. et al. Proatherogenic conditions promote autoimmune T helper 17 cell responses in vivo. Immunity 40, 153–165 (2014).
Park, H.-J. et al. Insights into the role of follicular helper T cells in autoimmunity. Immune Netw. 14, 21–29 (2014).
Yuan, J., Li, L. I., Wang, Z., Song, W. & Zhang, Z. Dyslipidemia in patients with systemic lupus erythematosus: association with disease activity and B-type natriuretic peptide levels. Biomed. Rep. 4, 68–72 (2016).
Chung, C. P. et al. Inflammatory mechanisms affecting the lipid profile in patients with systemic lupus erythematosus. J. Rheumatol. 34, 1849 (2007).
Baudino, L., Azeredo da Silveira, S., Nakata, M. & Izui, S. Molecular and cellular basis for pathogenicity of autoantibodies: lessons from murine monoclonal autoantibodies. Springer Semin. Immunopathol. 28, 175–184 (2006).
Tangye, S. G., Ma, C. S., Brink, R. & Deenick, E. K. The good, the bad and the ugly—TFH cells in human health and disease. Nat. Rev. Immunol. 13, 412–426 (2013).
Shortman, K. & Liu, Y.-J. Mouse and human dendritic cell subtypes. Nat. Rev. Immunol. 2, 151–161 (2002).
Reynolds, C. M. et al. Dietary saturated fatty acids prime the NLRP3 inflammasome via TLR4 in dendritic cells—implications for diet-induced insulin resistance. Mol. Nutr. Food Res. 56, 1212–1222 (2012).
Hong, C. & Tontonoz, P. Liver X receptors in lipid metabolism: opportunities for drug discovery. Nat. Rev. Drug Discov. 13, 433 (2014).
Castrillo, A. et al. Crosstalk between LXR and Toll-like receptor signaling mediates bacterial and viral antagonism of cholesterol metabolism. Mol. Cell 12, 805–816 (2003).
Collins, J. L. et al. Identification of a nonsteroidal liver X receptor agonist through parallel array synthesis of tertiary amines. J. Med. Chem. 45, 1963–1966 (2002).
Stumhofer, J. S. et al. Interleukins 27 and 6 induce STAT3-mediated T cell production of interleukin 10. Nat. Immunol. 12, 1363–1371 (2007).
Snapper, C. M. et al. Induction of IgG3 secretion by interferon gamma: a model for T cell-independent class switching in response to T cell-independent type 2 antigens. J. Exp. Med. 175, 1367 (1992).
Mozaffarian, D. F. et al. Executive summary: heart disease and stroke statistics—2016 update: a report from the American Heart Association. Circulation 133, 447–454 (2016).
Batten, M. et al. IL-27 supports germinal center function by enhancing IL-21 production and the function of T follicular helper cells. J. Exp. Med. 207, 2895 (2010).
Nurieva, R. I. et al. Generation of T follicular helper cells is mediated by interleukin-21 but independent of T helper 1, 2, or 17 cell lineages. Immunity 29, 138–149 (2008).
Owaki, T. et al. A role for IL-27 in early regulation of Th1 differentiation. J. Immunol. 175, 2191 (2005).
Vijayan, D. et al. IL-27 directly enhances germinal center B cell activity and potentiates lupus in Sanroque mice. J. Immunol. 197, 3008 (2016).
Koch, M. et al. The transcription factor T-bet controls regulatory T cell homeostasis and function during type 1 inflammation. Nat. Immunol. 10, 595–602 (2009).
Barbi, J., Oghumu, S., Lezama-Davila, C. M. & Satoskar, A. R. IFN-γ and STAT1 are required for efficient induction of CXC chemokine receptor 3 (CXCR3) on CD4+ but not CD8+ T cells. Blood 110, 2215–2216 (2007).
Chung, Y. et al. Follicular regulatory T (Tfr) cells with dual Foxp3 and Bcl6 expression suppress germinal center reactions. Nat. Med. 17, 983–988 (2011).
Chang, J.-H. & Chung, Y. Regulatory T cells in B cell follicles. Immune Netw. 14, 227–236 (2014).
Lee, S. K. et al. Interferon-γ excess leads to pathogenic accumulation of follicular helper T cells and germinal centers. Immunity 37, 880–892 (2012).
Miyauchi, K. et al. Protective neutralizing influenza antibody response in the absence of T follicular helper cells. Nat. Immunol. 17, 1447 (2016).
Wang, L. et al. Selective depletion of CD11c+CD11b+ dendritic cells partially abrogates tolerogenic effects of intravenous MOG in murine EAE. Eur. J. Immunol. 46, 2454–2466 (2016).
Shin, C. et al. CD8α– dendritic cells induce antigen-specific T follicular helper cells generating efficient humoral immune responses. Cell Reports 11, 1929–1940 (2015).
Joseph, S. B., Castrillo, A., Laffitte, B. A., Mangelsdorf, D. J. & Tontonoz, P. Reciprocal regulation of inflammation and lipid metabolism by liver X receptors. Nat. Med. 9, 213 (2003).
Jin, W. et al. Elevated circulating interleukin-27 in patients with coronary artery disease is associated with dendritic cells, oxidized low-density lipoprotein, and severity of coronary artery stenosis. Mediators Inflamm. 2012, 10 (2012).
Leng, C.-H. et al. A recombinant lipoprotein containing an unsaturated fatty acid activates NF-κB through the TLR2 signaling pathway and induces a differential gene profile from a synthetic lipopeptide. Mol. Immunol. 47, 2015–2021 (2010).
Kim, H. S., Go, H., Akira, S. & Chung, D. H. TLR2-mediated production of IL-27 and chemokines by respiratory epithelial cells promotes bleomycin-induced pulmonary fibrosis in mice. J. Immunol. 187, 4007 (2011).
Gringhuis, S. I. et al. Fucose-based PAMPs prime dendritic cells for follicular T helper cell polarization via DC-SIGN-dependent IL-27 production. Nat. Commun. 5, 5074 (2014).
Mills, E. L., Kelly, B. & O’Neill, L. A. J. Mitochondria are the powerhouses of immunity. Nat. Immunol. 18, 488 (2017).
O’Neill, L. A. J. & Pearce, E. J. Immunometabolism governs dendritic cell and macrophage function. J. Exp. Med. 213, 15–23 (2016).
Dorosz, S. A. et al. Role of calprotectin as a modulator of the IL27-mediated proinflammatory effect on endothelial cells. Mediators Inflamm. 2015, 16 (2015).
Qiu, H.-N., Liu, B., Liu, W. & Liu, S. Interleukin-27 enhances TNF-α-mediated activation of human coronary artery endothelial cells. Mol. Cell. Biochem. 411, 1–10 (2016).
Xia, L. P., Li, B. F., Shen, H. & Lu, J. Interleukin-27 and interleukin-23 in patients with systemic lupus erythematosus: possible role in lupus nephritis. Scand. J. Rheumatol. 44, 200–205 (2015).
Pan, H.-F., Tao, J.-H. & Ye, D.-Q. Therapeutic potential of IL-27 in systemic lupus erythematosus. Expert Opin. Ther. Targets 14, 479–484 (2010).
Yoo, S.-A. et al. Arginine-Rich anti-vascular endothelial growth factor (anti-VEGF) hexapeptide inhibits collagen-induced arthritis and VEGF-stimulated productions of TNF-α and IL-6 by human monocytes. J. Immunol. 174, 5846 (2005).
Kim, Y. U., Lim, H., Jung, H. E., Wetsel, R. A. & Chung, Y. Kim, Y. U., Lim, H., Jung, H. E., Wetsel, R. A. & Chung, Y. Regulation of autoimmune germinal center reactions in lupus-prone BXD2 mice byfollicular helper T cells. PLoS One 10, e0120294 (2015).